Boston Scientific Corp. (Symbol: BSX) has initiated trading on new options for expiration in March 2027. The $70.00 put option has a current bid of $7.70, allowing investors to potentially acquire shares at an effective cost of $62.30, providing a 1% discount from the current trading price of $70.43. Current odds indicate a 62% chance that this put option may expire worthless, leading to an 11.00% return on cash commitment, or 11.03% annualized.
Additionally, a $75.00 call option is available with a bid of $8.50, which could render an 18.56% total return if exercised. This call option is about 6% out-of-the-money, with a 45% probability of expiring worthless, allowing investors to keep both their shares and the collected premium, potentially yielding an additional 12.07% return, or 12.10% annualized.
Both the put and call contracts feature an implied volatility of approximately 39%. The trailing twelve-month volatility is calculated at 31%, based on the last 251 trading days.
